Led by specialist consultant Nathan Sharpe, Diagnostics Digest invites thought leaders to discuss industry insights and the latest news and trends in the diagnostics space.
Nathan works across Point-of-Care Diagnostics on a global scale. He is fascinated by the way in which Point of Care testing is vitally affecting our everyday lives and is always looking to connect with innovative individuals and organisations working in this area. Nathan provides recruitment services for both commercial and non-commercial roles.
CM Life Science is a solution focussed executive search firm. That's why our specialist consultants work with our clients and candidates to provide a bespoke recruitment service that mirrors their individual objectives.
Hosted on Acast. See acast.com/privacy for more information.
Led by specialist consultant Nathan Sharpe, Diagnostics Digest invites thought leaders to discuss industry insights and the latest news and trends in the diagnostics space.
Nathan works across Point-of-Care Diagnostics on a global scale. He is fascinated by the way in which Point of Care testing is vitally affecting our everyday lives and is always looking to connect with innovative individuals and organisations working in this area. Nathan provides recruitment services for both commercial and non-commercial roles.
CM Life Science is a solution focussed executive search firm. That's why our specialist consultants work with our clients and candidates to provide a bespoke recruitment service that mirrors their individual objectives.
Hosted on Acast. See acast.com/privacy for more information.
In part two of this three-part discussion, Adam and Dennis discuss the key barriers for entry for companies expanding into new territories and how to overcome these, whether you're a start-up or established company entering the market.
Dennis brings insight from his broad and brilliant background in molecular oncology and precision medicine, with experience in all elements from research to pharma and commercial. Discussing the challenges and opportunities he's faced as the CEO of Predicine in Europe.
This conversation comes in three parts. In part one, the pair discussed the importance of liquid biopsy for the future oncology market. Part three discusses new liquid biopsy technologies and what's new at Predicine. Be sure to subscribe to be notified when all parts are available.
If you'd like to get in touch about this episode, be a future podcast guest, or learn more about CM Life Science's services, please email Adam at adam.hargeaves@lifesci-cm.com.
Hosted on Acast. See acast.com/privacy for more information.